Italian lawyers fear French UPC ‘landgrab’

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Italian lawyers fear French UPC ‘landgrab’

Europe viewed from space at night with city lights in European Union member states, global EU business and finance, satellite communication technology, 3D render of planet Earth, world map from NASA

Milan may only fulfil its UPC dream at a price, with a decision from negotiations between France and Germany expected shortly

Italian lawyers fear Milan’s potential Unified Patent Court central division will miss out on key pharmaceutical cases if talks with France and Germany result in some life sciences cases being heard in Paris.

A spokesperson for Germany’s Ministry of Justice (MoJ) confirmed to Managing IP yesterday, March 13, that trilateral discussions with Italy and fellow UPC central division host France were ongoing and that a decision is expected “shortly”.

Milan is the only contender to host the third central division seat, which was originally assigned to London before the UK quit the UPC project in 2020.

The London division was expected to specialise in life sciences cases.

The other two central seats are in Paris and Munich.

Italy bid for Milan to replace London on the basis that its division would assume responsibility for life sciences cases.

However, a report in the Italian newspaper Il Sole 24 Ore last month said that the original allocation of cases to the different central divisions was under debate.

France and Germany have, according to that report, proposed that the Paris division should hear cases involving pharmaceutical patents for which a supplementary protection certificate (SPC) is in effect.

That would leave the proposed Milan division with non-SPC pharma cases, a prospect that has alarmed some Italian practitioners who campaigned for Milan to host the seat.

Laura Orlando, joint global head of IP at Herbert Smith Freehills in Milan, said the rumoured proposal appeared to be a “landgrab” with no legal basis.

She added that a split between SPC and non-SPC cases would be entirely arbitrary and impractical from an enforcement perspective.

“This new debate on the competence of the third central division appears to stem from purely political considerations, which worryingly do not take into account the technical and legal context,” Orlando told Managing IP.

But while the Italian legal sector has reacted mostly negatively to the proposal, some practitioners think a compromise might be worthwhile.

Roberto Valenti, partner at DLA Piper in Milan, said a compromise on SPC cases would be worth it if the Milan division could start hearing cases from when the UPC opens in June.

“The third central division is extremely important, not only for Italy but for the system as a whole.

“I hope parties agree on a solution now rather than later,” Valenti said.

A spokesperson for Germany’s MoJ said the establishment of a central division in Milan would require an amendment to the UPC Agreement (UPCA), which still references London.

Munich and Paris will temporarily assume all central division responsibilities if no deal to amend the UPCA has been reached by the time the court opens on June 1, she added.

more from across site and SHARED ros bottom lb

More from across our site

Arrival of Laura Alsonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Gift this article